Your browser doesn't support javascript.
loading
Retreatment of Egyptian Chronic Hepatitis C Patients Not Responding to Pegylated Interferon and Ribavirin Dual Therapy.
Aboushady, Mohamed; Alwassief, Ahmed; Abdelrazik, Mohamed; Ziada, Dina; Shahba, Hossam; Elmestikawy, Amr; Elbahrawy, Ashraf.
Afiliação
  • Aboushady M; Department of Internal Medicine, Al-Azhar University, Cairo, Egypt.
  • Alwassief A; Department of Internal Medicine, Al-Azhar University, Cairo, Egypt.
  • Abdelrazik M; Department of Internal Medicine, Kafr Elsheikh Liver Research Center, Kafr Elsheikh, Egypt.
  • Ziada D; Deartment of Tropical Medicine and Infectious Diseases, Tanta University, Tanta, Egypt.
  • Shahba H; Department of Internal Medicine, Al-Azhar University, Cairo, Egypt.
  • Elmestikawy A; Department of Internal Medicine, Al-Azhar University, Cairo, Egypt.
  • Elbahrawy A; Department of Internal Medicine, Al-Azhar University, Cairo, Egypt.
J Interferon Cytokine Res ; 39(9): 539-546, 2019 09.
Article em En | MEDLINE | ID: mdl-31173550
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Polietilenoglicóis / Ribavirina / Interferon-alfa / Hepatite C Crônica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Polietilenoglicóis / Ribavirina / Interferon-alfa / Hepatite C Crônica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Ano de publicação: 2019 Tipo de documento: Article